Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The treatment improved hair growth and was well-received without side effects.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Taking five small dutasteride capsules is the same as taking one larger capsule.

A new score can help predict which patients might have trouble urinating after prostate surgery.

The method effectively measures drug impact on DHT levels in prostate treatments.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Combination therapy is more effective for prostate volumes over 60 ml.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

MK-386 lowers DHT in blood and skin but not in semen.

A new combination of tadalafil and finasteride improves drug performance and stability.

SHPro® improved urinary symptoms and erectile function in men and is safe.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Finasteride reduces bleeding during prostate surgery.

The new gel for hair loss is safe, effective, and reduces side effects.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.